Pay in 4 interest-free payments of $28.50 Learn more
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8
50(2):355-67
PubMed Central PMCID: PMC4082357
AZD4205 is a selective JAK1 inhibitor
2-dihydro-[3
Fezolinetant HCl Size:10 mg solid 50(2):355-67Fezolinetant, also known as ESN 364, is Neurokinin 3 (NK 3) receptor antagonist which has been optimized for use in womens health, and is being developed for sex hormone related disorders such as endometriosis, polycystic ovarian syndrome and uterine fibroids. Fexolinetant allows modulation of the hypothalamic pituitary gonadal axis with a selective action on hormones relevant to disease. The agent is expected to have greater tolerability than
US$ 42.80
US$ 108.68
US$ 402.21
US$ 25.00
US$ 44.00
US$ 74.71
US$ 945.69
US$ 10.30
US$ 191.18
US$ 245.92
US$ 26.56
US$ 10.23